Furthermore, ECA has been demonstrated to suppress the epithelial-mesenchymal transition (EMT) process induced by SPC or TGF-β1 in lung cancer cells by inhibiting Wnt activation via downregulation of NDP expression [12]. The gene discussed is NDP; the disease is lung carcinoma.